Squarepoint’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-12,859
| Closed | -$212K | – | 2742 |
|
2024
Q4 | $212K | Buy |
+12,859
| New | +$212K | ﹤0.01% | 2360 |
|
2024
Q3 | – | Sell |
-21,648
| Closed | -$548K | – | 2519 |
|
2024
Q2 | $548K | Sell |
21,648
-30,809
| -59% | -$780K | ﹤0.01% | 1680 |
|
2024
Q1 | $1.33M | Sell |
52,457
-6,098
| -10% | -$155K | ﹤0.01% | 1201 |
|
2023
Q4 | $1.33M | Buy |
58,555
+38,835
| +197% | +$880K | ﹤0.01% | 1218 |
|
2023
Q3 | $367K | Buy |
+19,720
| New | +$367K | ﹤0.01% | 1806 |
|
2022
Q2 | – | Sell |
-19,288
| Closed | -$484K | – | 2104 |
|
2022
Q1 | $484K | Buy |
+19,288
| New | +$484K | ﹤0.01% | 1511 |
|
2021
Q4 | – | Sell |
-4,921
| Closed | -$209K | – | 2516 |
|
2021
Q3 | $209K | Sell |
4,921
-7,015
| -59% | -$298K | ﹤0.01% | 1804 |
|
2021
Q2 | $517K | Buy |
11,936
+6,074
| +104% | +$263K | ﹤0.01% | 1585 |
|
2021
Q1 | $239K | Buy |
5,862
+489
| +9% | +$19.9K | ﹤0.01% | 2047 |
|
2020
Q4 | $243K | Buy |
+5,373
| New | +$243K | ﹤0.01% | 2007 |
|
2020
Q1 | – | Sell |
-28,153
| Closed | -$1.46M | – | 1825 |
|
2019
Q4 | $1.46M | Buy |
28,153
+13,545
| +93% | +$702K | 0.01% | 1063 |
|
2019
Q3 | $802K | Buy |
+14,608
| New | +$802K | 0.01% | 1336 |
|
2019
Q2 | – | Sell |
-9,800
| Closed | -$296K | – | 2272 |
|
2019
Q1 | $296K | Sell |
9,800
-11,763
| -55% | -$355K | ﹤0.01% | 1733 |
|
2018
Q4 | $725K | Buy |
+21,563
| New | +$725K | 0.01% | 1045 |
|
2018
Q2 | – | Sell |
-10,536
| Closed | -$524K | – | 1730 |
|
2018
Q1 | $524K | Buy |
10,536
+4,026
| +62% | +$200K | 0.01% | 1071 |
|
2017
Q4 | $351K | Sell |
6,510
-527
| -7% | -$28.4K | 0.01% | 1398 |
|
2017
Q3 | $408K | Buy |
+7,037
| New | +$408K | 0.01% | 1035 |
|
2016
Q3 | – | Sell |
-3,955
| Closed | -$212K | – | 998 |
|
2016
Q2 | $212K | Buy |
+3,955
| New | +$212K | 0.01% | 872 |
|